Skip to content

Alto Neuroscience ANRO Interest Income

Interest Income at other companies

Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$6.91M-14.5%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$4.36M+43.1%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$189K-80.5%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$2.85M+1,108%
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
$2.47M+205%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
-$1.19M+51.3%

Other financials

Income statement

See full
Operating income-$27.1M-73.1%
Net income-$26.2M-73.0%
EPS (diluted)-$0.80-42.9%

Balance sheet

See full
Cash & equivalents$264.3M+63.9%
Total debt$20.9M-17.2%
Total equity$243.4M+75.0%
Total assets$276.3M+60.7%

Cash flow

See full
Operating cash flow-$27.1M-63.6%
CapEx$556.0K+2,217%
Free cash flow-$27.6M-66.7%

Valuation

See full
Market cap$874.19M+1,335%
Enterprise value$630.81M-940%

Returns & leverage

See full
Return on equity-38.9%+0.9pp
Debt / equity0.1×-0.1×
Current ratio20.5×-2.0×

Where this comes from

Reported directly by Alto Neuroscience in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alto Neuroscience's interest income?
Alto Neuroscience (ANRO) reported interest income of $1.56M in Q1 2026.
How has Alto Neuroscience's interest income changed year-over-year?
Alto Neuroscience's interest income decreased by 14.6% year-over-year, from $1.83M to $1.56M.
What is the long-term trend for Alto Neuroscience's interest income?
Over 2 years (2023 to 2025), Alto Neuroscience's interest income has grown at a 67.7% compound annual growth rate (CAGR), from $2.35M to $6.6M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.